Response to: 'Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the artcile by Singh and Clevland' by Quills et al

Ann Rheum Dis. 2022 Jul;81(7):e125. doi: 10.1136/annrheumdis-2020-218263. Epub 2020 Jul 2.

Author

Jasvinder A Singh^{1

2}

Affiliations

¹ Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA jasvinder.md@gmail.com.
² Medicine Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA.

PMID: 32616606
DOI: 10.1136/annrheumdis-2020-218263

No abstract available

Keywords: epidemiology; immune complex diseases; pharmacogenetics.

Publication types

Letter
Comment

MeSH terms

Allopurinol / adverse effects
Febuxostat / adverse effects
Gout Suppressants / adverse effects
Gout* / drug therapy
Humans
Hyperuricemia* / drug therapy
Skin

Substances

Gout Suppressants
Febuxostat
Allopurinol